LACTOZYME - CAP DIN 02138077
Health Canada record
| Active ingredient(s) | ASPERGILLUS ORYZAE 3000 UNIT |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | |
| Original market date | 31-Dec-1995 |
| Current status date | 01-Jul-2004 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jamieson Laboratories Ltd. — licence 100166, currently licensed, last inspection rating C (2022-05-17).
No Canadian shortage report is currently matched to this DIN.
Request a quote for LACTOZYME - CAP